# K142619: Snap Insulin Pump System

- Pathway: 510(k) (Special)
- Applicant: Asante Solutions, Inc.
- Decided: Dec 18, 2014 after 93 days
- Product code: LZG (Pump, Infusion, Insulin)
- Device class: 2
- Regulation: 21 CFR 880.5725
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K905693 (1991). 9 ancestors in all.
No later device cites it as a predicate yet.
0 of 10 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K122483: Pearl Diabetes Management System, Asante Solutions, Inc. (2013) Summary page 4.

## Indications for use
The Asante Snap Insulin Pump System is indicated for continuous, subcutaneous delivery of insulin at programmable basal and bolus rates for the management of diabetes mellitus in adult patients requiring insulin.

Source page: https://510kreport.com/device/K142619
Methodology: https://510kreport.com/methodology